Bringing research progress into focus—read the 2024 SRF Annual Report!
We’re excited to share our 2024 SRF Annual Report. Together, we’ve helped fund groundbreaking scleroderma research, expand access to trusted educational resources, and raise awareness on a global scale.
With your support, we launched global enrollment for CONQUEST, the first-ever international scleroderma clinical trial; empowered top researchers to drive innovation and collaboration; and expanded our library of trusted educational tools for people living with scleroderma and their care teams.
This work is only possible because of the dedicated scleroderma community. Thank you for helping us push progress forward, together.
Read the full report: https://srfcure.org/about/annual-report/
